HP, Tschöpe C, Cooper LT, Camici PG. Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document. Circ Heart Fail. 2020 Nov;13(11):e007405. \[[PMC free article: PMC7673642](/pmc/articles/PMC7673642/)\] \[[PubMed: 33176455](https://pubmed.ncbi.nlm.nih.gov/33176455)\] 68. Dous GV, Grigos AC, Grodman R. Elevated troponin in patients with acute stroke - Is it a true heart attack? Egypt Heart J. 2017 Sep;69(3):165-170. \[[PMC free article: PMC5883484](/pmc/articles/PMC5883484/)\] \[[PubMed: 29622972](https://pubmed.ncbi.nlm.nih.gov/29622972)\] 69. Etgen T, Baum H, Sander K, Sander D. Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis. Stroke. 2005 Feb;36(2):270-5. \[[PubMed: 15604421](https://pubmed.ncbi.nlm.nih.gov/15604421)\] 70. Kraus D, von Jeinsen B, Tzikas S, Palapies L, Zeller T, Bickel C, Fette G, Lackner KJ, Drechsler C, Neumann JT, Baldus S, Blankenberg S, Münzel T, Wanner C, Zeiher AM, Keller T. Cardiac Troponins for the Diagnosis of Acute Myocardial Infarction in Chronic Kidney Disease. J Am Heart Assoc. 2018 Oct 02;7(19):e008032. \[[PMC free article: PMC6404905](/pmc/articles/PMC6404905/)\] \[[PubMed: 30371308](https://pubmed.ncbi.nlm.nih.gov/30371308)\] 71. Ren D, Huang T, Liu X, Xu G. High-sensitive cardiac troponin for the diagnosis of acute myocardial infarction in different chronic kidney disease stages. BMC Cardiovasc Disord. 2021 Feb 17;21(1):100. \[[PMC free article: PMC7888109](/pmc/articles/PMC7888109/)\] \[[PubMed: 33596833](https://pubmed.ncbi.nlm.nih.gov/33596833)\] 72. Parikh RH, Seliger SL, deFilippi CR. Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction. Clin Biochem. 2015 Mar;48(4-5):247-53. \[[PubMed: 25617663](https://pubmed.ncbi.nlm.nih.gov/25617663)\] 73. Korff S, Katus HA, Giannitsis E. Differential diagnosis of elevated troponins. Heart. 2006 Jul;92(7):987-93. \[[PMC free article: PMC1860726](/pmc/articles/PMC1860726/)\] \[[PubMed: 16775113](https://pubmed.ncbi.nlm.nih.gov/16775113)\] 74. Han X, Zhang S, Chen Z, Adhikari BK, Zhang Y, Zhang J, Sun J, Wang Y. Cardiac biomarkers of heart failure in chronic kidney disease. Clin Chim Acta. 2020 Nov;510:298-310. \[[PubMed: 32710942](https://pubmed.ncbi.nlm.nih.gov/32710942)\] 75. Harley K, Bissonnette S, Inzitari R, Schulz K, Apple FS, Kavsak PA, Gunsolus IL. Independent and combined effects of biotin and hemolysis on high-sensitivity cardiac troponin assays. Clin Chem Lab Med. 2021 Jul 27;59(8):1431-1443. \[[PubMed: 33761581](https://pubmed.ncbi.nlm.nih.gov/33761581)\] 76. Januzzi JL, Hahn SS, Chae CU, Giugliano R, Lewandrowski K, Theroux P, Jang IK. Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes. Am J Cardiol. 2000 Oct 01;86(7):713-7. \[[PubMed: 11018188](https://pubmed.ncbi.nlm.nih.gov/11018188)\] 77. Sanders A, Gama R, Ashby H, Mohammed P. Biotin immunoassay interference: A UK-based prevalence study. Ann Clin Biochem. 2021 Jan;58(1):66-69. \[[PubMed: 32936669](https://pubmed.ncbi.nlm.nih.gov/32936669)\] 78. Dasgupta A. Immunoassay design and biotin interference. Adv Clin Chem. 2022;109:165-183. \[[PubMed: 35953126](https://pubmed.ncbi.nlm.nih.gov/35953126)\] 79. Ismail AA, Walker PL, Cawood ML, Barth